Annual Review of Cancer Biology

Papers
(The TQCC of Annual Review of Cancer Biology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Immune Cell Metabolism and Immuno-Oncology107
Distinct Essentiality of the Mitochondrial Respiratory Chain in Proliferating Cells In Vivo40
YAP, TAZ, and Hippo-Dysregulating Fusion Proteins in Cancer35
lncRNAs as Targetable Nodes of Oncogenic Networks Underlying Cancer Progression and Therapy Resistance35
Lessons from 3D Reconstruction of Cancer32
Advances in Therapies Targeting Inhibitory Checkpoint Receptors: TIGIT, LAG-3, and Beyond32
Mitochondria, OXPHOS, and Cancer Progression: A Modular View27
Natural and Engineered Cytokines as Cancer Therapeutics22
Allogeneic CAR T Cell Therapy for Cancer21
Therapeutic Discovery for Chromatin Complexes: Where Do We Stand?20
Beyond Mice and Men: Alternative Vertebrate and Invertebrate Models in Cancer Biology19
They Contain Multitudes: The Diverse Roles of CD4+ T Cells in Cancer Immunity16
Road Map to Defeat Pancreatic Cancer15
Cancer Cell Polarity and Extrusion15
Stalled CARs: Mechanisms of Resistance to CAR T Cell Therapies15
Cancer Dependency Map: Past and Present15
An Erratic Path Toward Discovery14
Engineering Cancer with Next-Generation Genome Editing Tools14
Targeting RAS for Cancer Treatment: What a Long, Strange Trip It's Been14
Strategies for Heating Up Cold Tumors to Boost Immunotherapies12
The Effects of Clonal Heterogeneity on Cancer Immunosurveillance12
The Angiocrine Niche in Cancer Therapy Responses: The Role of Vascular Endothelial Cells in Immunomodulation12
Rationales for Combining Therapies to Treat Cancer: Independent Action, Response Correlation, and Collateral Sensitivity Versus Synergy12
0.11117005348206